Physician profile
Oliver T Chen
NPI 1245332089
$1,664.31
in general payments reported to CMS, 2019-2025
17 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $47.06 · 2021: $160 · 2022: $240 · 2023: $236 · 2024: $280 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $470.88 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $218.41 | 2019-2021 | |
| Abbvie INC. | $214.19 | 2022-2025 | |
| Harrow Eye, LLC | $130.32 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $120.00 | 2019 | |
| Bausch & Lomb Americas INC. | $96.55 | 2022-2024 | Miebo, Xiidra, Envista Mx60 Iol |
| Alcon Vision LLC | $81.56 | 2020-2025 | Hydrus Microstent, Tryptyr |
| Allergan, INC. | $57.02 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $51.62 | 2024-2025 | Xdemvy |
| Thea Pharma INC. | $47.22 | 2023 | Iyuzeh |
| Amgen INC. | $37.08 | 2024 | Tepezza |
| Mallinckrodt Hospital Products INC. | $34.43 | 2021 | |
| Astellas Pharma US INC | $26.81 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $26.35 | 2022 | |
| Rxsight INC | $18.46 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $17.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.